In addition, we confirmed the critical role of ARGs, including NKX2-3 and FADD, during the occurrence and development of HNSCC for the first time, which can be used as a diagnostic biomarker and a therapeutic target for HNSCC. The gene discussed is NKX2-3; the disease is head and neck squamous cell carcinoma.